Market cap
$107.251 B
$52.96 +1.51%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
—
Not reported
Shares outstanding
4,315,445,026
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations — ranked by market cap
All 501 →Where these numbers come from
Share counts and financials for GSK are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.